This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Johns Hopkins University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations by John Clayton Hall
Introduction
John Clayton Hall is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical research, particularly in understanding the role of interferons in autoimmune diseases. His work has implications for diagnosis, monitoring, and therapy in various medical conditions.
Latest Patents
John Clayton Hall holds a patent titled "Methods for identifying patterns of IFN induced expression and use in diagnosis, monitoring and therapy." This patent describes the identification of a subpopulation of genes induced by type I and type II interferons in a human submandibular gland epithelial cell line. The findings reveal that many genes highly up-regulated by IFN-α are also significantly induced by IFN-γ, while a distinct group of genes is exclusively induced by IFN-γ. This research enables the discernment of different interferon patterns in target tissues, allowing for more precise molecular classification of patient subpopulations. The identified gene probes are instrumental in selecting and monitoring therapy, as well as defining the efficacy of novel agents in autoimmune rheumatic diseases. He has 1 patent to his name.
Career Highlights
John Clayton Hall is affiliated with Johns Hopkins University, where he continues to advance research in his field. His work has garnered attention for its innovative approach to understanding gene expression patterns and their clinical applications.
Collaborations
He has collaborated with notable colleagues, including Livia Angela Casciola-Rosen and Antony Rosen, contributing to a rich environment of research and innovation.
Conclusion
John Clayton Hall's contributions to the field of biomedical research through his patent and collaborations highlight the importance of innovation in understanding and treating autoimmune diseases. His work continues to pave the way for advancements in medical diagnostics and therapies.